novo-cefaclor capsule
teva canada limited - cefaclor - capsule - 500mg - cefaclor 500mg - second generation cephalosporins
aclor cefaclor 250mg/5ml (as monohydrate) powder for oral liquid bottle
viatris pty ltd - cefaclor monohydrate, quantity: 53.72 mg/ml (equivalent: cefaclor, qty 50 mg/ml) - oral liquid, powder for - excipient ingredients: methylcellulose; sodium lauryl sulfate; dimeticone 350; xanthan gum; tapioca starch; erythrosine; sucrose; flavour - aclor is indicated for the treatment of the following types of infections caused by or likely to be caused by susceptible organisms: lower respiratory infections, including pneumonia, bronchitis and exacerbations of chronic bronchitis. upper respiratory tract infections, including pharyngitis, tonsillitis and otitis media. skin and skin structure infections. urinary tract infections including pyelonephritis and cystitis. note: 1. penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. aclor appears to be as effective as phenoxymethyl penicillin in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of aclor in the subsequent prevention of rheumatic fever are not available at present. 2. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefaclor.
cefaclor gh
ranbaxy australia pty ltd - cefaclor monohydrate -
cefaclor-ga
actavis pty ltd - cefaclor monohydrate -
cefaclor capsule
mm therapeutics inc - cefaclor - capsule - 250mg - cefaclor 250mg - second generation cephalosporins
cefaclor capsule
mm therapeutics inc - cefaclor - capsule - 500mg - cefaclor 500mg - second generation cephalosporins
cefaclor suspension
mm therapeutics inc - cefaclor - suspension - 125mg - cefaclor 125mg - second generation cephalosporins
cefaclor suspension
mm therapeutics inc - cefaclor - suspension - 250mg - cefaclor 250mg - second generation cephalosporins
cefaclor suspension
mm therapeutics inc - cefaclor - suspension - 375mg - cefaclor 375mg - second generation cephalosporins
ranbaxy-cefaclor sr
douglas pharmaceuticals limited - cefaclor monohydrate 405.27mg equivalent to cefaclor 375 mg - modified release tablet - 375 mg - active: cefaclor monohydrate 405.27mg equivalent to cefaclor 375 mg excipient: colloidal silicon dioxide hyprolose hypromellose lactose monohydrate magnesium stearate opacode opadry blue purified talc